Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Galenea Corp.
At least two companies in the neuroscience space are set to deliver potentially good news by year’s end, with other promising candidates in the offing, according to industry consultant Harry Tracy, who compiled a list of the top 10 partnering opportunities in the field for the upcoming Therapeutic Area Partnerships meeting.
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
The CEO of one of China’s hottest start-ups sits down to talk about his strategy, the state of innovation in China and how to access funding from the Chinese government.
- Drug Discovery Tools